How does PT-141 work in your body
Cox GF, Sleeper LA, Lowe AM et al : Factors associated with establishing a causal diagnosis for children with cardiomyopathy
At week 36, the following differences were observed for change in 24-hour diastolic blood pressure from baseline relative to placebo therapy: Tirzepatide 5 mg: -2.0 (95% CI, -3.6 to -0.3) mmHg Tirzepatide 10 mg: -2.9 (95% CI, -4.5 to -1.3) mmHg Tirzepatide 15 mg: -0.5 (95% CI, -2.0 to 1.1) mmHg Further analysis suggested these results were consistent across subgroups defined by clinically relevant factors, including age, sex, BMI, and hypertension-related factors
Intentional appetite suppression can work against those goals
SGLT2 Inhibitors Are Associated With Reduced Cardiovascular Disease in Patients With Type 2 Diabetes: An Analysis of Real-World Data
Both are GLP-1 receptor agonists used for weight management